NIH-funded research Fellowship grant

How C. elegans cells take in double-stranded RNA and cholesterol

Official title: Import of double-stranded RNA and cholesterol into cells in C. elegans

Funded at Univ of Maryland, College Park · NIH-10996829 · Data updated 2026-11-12

This study is looking at how tiny worms called C. elegans move important molecules like double-stranded RNA and cholesterol into their cells, which could help us find better ways to deliver treatments for heart-related issues and conditions linked to cholesterol.

Quick facts

Grant typeFellowship grant
Study typeNIH-funded research
Funding institutionUniv of Maryland, College Park
NIH-funded
Lab location1 site (College Park, United States)
Project startJanuary 1, 2025
Project endDecember 31, 2027
Funding year2024
Award (this year)$42,547
NIH project number1F31HL176186-01
Project IDNIH-10996829 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals with cardiovascular diseases or conditions related to cholesterol metabolism.

Less likely to help

Patients with non-cardiovascular conditions or those not affected by cholesterol metabolism issues may not benefit from this research.

What this research studies

This research investigates how the nematode C. elegans transports double-stranded RNA (dsRNA) and cholesterol into its cells, which is crucial for gene silencing and maintaining cholesterol balance. The study focuses on a specific protein, SID-1, that facilitates the movement of dsRNA between cells and explores its interaction with a newly identified cholesterol transporter. By understanding these mechanisms, the research aims to improve the delivery of RNA-based therapies for cardiovascular diseases. The findings could lead to advancements in how we treat conditions related to cholesterol metabolism and gene expression.

Why it matters

Potential benefit: If successful, this research could enhance the effectiveness of RNA-based therapies for cardiovascular diseases by improving how these therapies are delivered into cells.

How similar studies have gone: Other research has shown promise in using RNA interference for gene silencing, but the specific mechanisms of dsRNA transport in C. elegans are less explored, making this a novel investigation.

Where this research is happening

  • Univ of Maryland, College Park
    College Park, United States
    Active

Researchers

  • Principal investigator: Lowers, Victoria — Univ of Maryland, College Park
  • Study coordinator: Lowers, Victoria

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.